Merck, 1058339025, Magnesium chloride hexahydrate

Application

Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.: This study investigates the preparation and optimization of a drug delivery system utilizing berberine chloride-immobilized MgAl hydrotalcite. Magnesium chloride hexahydrate is involved in the synthesis of the hydrotalcite, which plays a crucial role in the stabilization and controlled release of berberine chloride. This research provides insights into the potential applications of magnesium chloride hexahydrate in developing advanced drug delivery systems, highlighting its importance in pharmaceutical formulations (Djebbi et al., 2016).

Analysis Note
Assay (complexometric): 99.0 - 101.0 %
Identity: conforms
Appearance of solution: passes test
Insoluble matter: ≤ 0.005 %
pH-value (5 %; water): 5.0 - 6.5
Acidity or alkalinity: passes test
Bromide (Br): ≤ 0.05 %
Nitrate (NO₃): ≤ 0.001 %
Phosphate (PO₄): ≤ 5 ppm
Sulfate (SO₄): ≤ 0.002 %
Total nitrogen (N): ≤ 0.0002 %
Heavy metals (ACS): ≤ 5 ppm
Heavy metals (as Pb): ≤ 0.0005 %
Al (Aluminium): ≤ 0.0002 %
As (Arsenic): ≤ 0.0002 %
Ba (Barium): ≤ 0.002 %
Ca (Calcium): ≤ 0.003 %
Cu (Copper): ≤ 0.0005 %
Fe (Iron): ≤ 5 ppm
K (Potassium): ≤ 0.001 %
Mn (Manganese): ≤ 5 ppm
Na (Sodium): ≤ 0.001 %
NH₄ (Ammonium): ≤ 0.002 %
Pb (Lead): ≤ 0.0005 %
Sr (Strontium): ≤ 0.005 %
Water: 51.0 - 55.0 %
Corresponds to ACS, ISO, Reag. Ph Eur
Other Notes
Replaces: MX0045; MX0045-1; MX0045-2; MX0045-4; MX0045-20
Legal Information
EMSURE is a registered trademark of Merck KGaA, Darmstadt, Germany